FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.
You may also be interested in...
Consumer Groups Back FDA On NDI Draft Guidance
The Consumers Union and National Consumers League suggest requiring NDI notifications for all nano-engineered supplements. The groups support FDA’s assertion that each NDI-containing supplement needs a notification, with CU saying industry’s NDI record is “grossly unfair to consumers.”
Consumer Groups Back FDA On NDI Draft Guidance
The Consumers Union and National Consumers League suggest requiring NDI notifications for all nano-engineered supplements. The groups support FDA’s assertion that each NDI-containing supplement needs a notification, with CU saying industry’s NDI record is “grossly unfair to consumers.”
FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.